Publication: 3263

Publication: 3263

Overall survival (OS) of comparing 3 vs 6 months of adjuvant (adjuv) oxaliplatin-based therapy for patients (pts) with stage III colon cancer (CC): Updated results from the IDEA (International Duration Evaluation of Adjuv chemotherapy) collaboration

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 38 (15_suppl) 4004

Meeting Instance:: ASCO 2020
Year:: 2020
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: 3380

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U10CA180888 (SWOG);

Corr. Author:
Authors:: Alberto F. Sobrero Andre Thierry Jeffrey A. Meyerhardt Axel Grothey Timothy Iveson Takayuki Yoshino John Souglakos Jeffrey P. Meyers Roberto Labianca Mark Saunders Dewi Vemerey Takeharu Yamanaka Ioannis Boukovinas Eiji Oki Vassilis Gerogoulias Valter Torri Andrea Harkin Julien Taieb Anthony F. Shields Qian Shi

Networks:: CORA, LAPS-MA036, LAPS-MN026

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80702
Phases:: 3

Keywords: